For further details see:
Immunovia GAAP EPS of -SEK 1.95, revenue of SEK 0.18Mhome / stock / immvf / immvf news
For further details see:
Immunovia GAAP EPS of -SEK 1.95, revenue of SEK 0.18MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Immunovia AB Company Name:
IMMVF Stock Symbol:
Market:
Immunovia Publishes Interim Report for January-March 2023 PR Newswire LUND, Sweden , May 23, 2023 /PRNewswire/ -- January- March 2023 Net sales amounted to kSEK 520 (182) divided by sales of tests kSEK 379 (122) and royalties kSEK 141(60). N...
Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states PR Newswire LUND, Sweden , May 23, 2022 /PRNewswire/ -- T...
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test PR Newswire LUND, Sweden , April 22, 2021 /PRNewswire/ -- Immunovia is launching its IMMray™ PanCan-d test in the US as a Laboratory Developed Test (LDT) in Q2 2021. The ...